Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
  1. 4 Planned sale EVP and Chief Legal Officer sold 694 shares at $404.21 ($280,522)
  2. 4 Planned sale Director sold 266 shares at $386.69 ($102,860)
  3. 4 Open-market buy CEO & President bought 10,000 shares at an average $389.58 ($3,895,768)
  4. 4 Open-market buy Director bought 5,000 shares at an average $389.68 ($1,948,416)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Shares withheld for taxes EVP, COO gave up 37,243 shares (to pay taxes)
  9. 4 Planned sale EVP, Chief Scientific Officer sold 52 shares at $424.69 ($22,084)
  10. 4 Grant or award EVP, COO acquired 37,622 shares (grant or award)
  11. 4 Grant or award Director acquired 796 shares (grant or award)
  12. 4 Grant or award Director acquired 398 shares (grant or award)
  13. 4 Grant or award Director acquired 796 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 796 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award Director acquired 398 shares (grant or award)
  18. 4 Grant or award Director acquired 796 shares (grant or award)
  19. 4 Planned sale Director sold 400 shares at $505.86 ($202,344)
  20. 4 Derivatives Options or other derivatives

Page 7 of 129 · 2,568 filings